BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23313637)

  • 1. Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease.
    Fiorito J; Saeed F; Zhang H; Staniszewski A; Feng Y; Francis YI; Rao S; Thakkar DM; Deng SX; Landry DW; Arancio O
    Eur J Med Chem; 2013 Feb; 60():285-94. PubMed ID: 23313637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain.
    Liu J; Wenzel B; Dukic-Stefanovic S; Teodoro R; Ludwig FA; Deuther-Conrad W; Schröder S; Chezal JM; Moreau E; Brust P; Maisonial-Besset A
    Pharmaceuticals (Basel); 2016 Apr; 9(2):. PubMed ID: 27110797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.
    Peixoto CA; Nunes AK; Garcia-Osta A
    Mediators Inflamm; 2015; 2015():940207. PubMed ID: 26770022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease.
    Lee L; Dale E; Staniszewski A; Zhang H; Saeed F; Sakurai M; Fa' M; Orozco I; Michelassi F; Akpan N; Lehrer H; Arancio O
    Sci Rep; 2014 Dec; 4():7190. PubMed ID: 25448527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders.
    Basavarajappa BS; Subbanna S
    Epigenomics; 2024 Mar; 16(5):331-358. PubMed ID: 38321930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE5 inhibitor drugs for use in dementia.
    Hainsworth AH; Arancio O; Elahi FM; Isaacs JD; Cheng F
    Alzheimers Dement (N Y); 2023; 9(3):e12412. PubMed ID: 37766832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives.
    ElHady AK; El-Gamil DS; Abdel-Halim M; Abadi AH
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic that disrupts PDE11A4 homodimerization in hippocampus CA1 reverses age-related cognitive decline of social memories in mice.
    Pilarzyk K; Capell WR; Porcher L; Rips-Goodwin A; Kelly MP
    Neurobiol Aging; 2023 Nov; 131():39-51. PubMed ID: 37572526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing metabolic stability of phosphodiesterase 5 inhibitors: Discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticity.
    Zuccarello E; Zhang H; Acquarone E; Pham D; Staniszewski A; Deng SX; Landry DW; Arancio O; Fiorito J
    Bioorg Med Chem Lett; 2023 Aug; 92():129409. PubMed ID: 37453616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrolytic elimination of ethylene from ethoxyquinolines and ethoxyisoquinolines: a computational study.
    Abdel-Rahman MA; Shibl MF; Mahmoud MAM
    Sci Rep; 2023 Apr; 13(1):6248. PubMed ID: 37069216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-Assisted Synthesis of Piperidinyl-Quinoline Acylhydrazones as New Anti-Alzheimer's Agents: Assessment of Cholinesterase Inhibitory Profile, Molecular Docking Analysis, and Drug-like Properties.
    Munir R; Zaib S; Zia-Ur-Rehman M; Hussain N; Chaudhry F; Younas MT; Zahra FT; Tajammul Z; Javid N; Dera AA; Ogaly HA; Khan I
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories.
    Pilarzyk K; Porcher L; Capell WR; Burbano SD; Davis J; Fisher JL; Gorny N; Petrolle S; Kelly MP
    Aging Cell; 2022 Oct; 21(10):e13687. PubMed ID: 36073342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the Viability of Tadalafil-Based
    Bailey JJ; Wuest M; Bojovic T; Kronemann T; Wängler C; Wängler B; Wuest F; Schirrmacher R
    ACS Omega; 2021 Aug; 6(33):21741-21754. PubMed ID: 34471776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microelectromechanical System Measurement of Platelet Contraction: Direct Interrogation of Myosin Light Chain Phosphorylation.
    George MJ; Litvinov J; Aroom K; Spangler LJ; Caplan H; Wade CE; Cox CS; Gill BS
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoline Derivative Enhances Human Sperm Motility and Improves the Functional Competence.
    Kumari S; Salian SR; Rao A; Somagond SM; Kamble RR; Nesaragi A; Das J; Rajanikant GK; Mutalik S; Raghu SV; Adiga SK; Kalthur G
    Reprod Sci; 2021 May; 28(5):1316-1332. PubMed ID: 33237520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.
    Alarcón-Espósito J; Mallea M; Rodríguez-Lavado J
    Curr Neuropharmacol; 2021; 19(6):832-867. PubMed ID: 32928087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau is not necessary for amyloid-β-induced synaptic and memory impairments.
    Puzzo D; Argyrousi EK; Staniszewski A; Zhang H; Calcagno E; Zuccarello E; Acquarone E; Fa' M; Li Puma DD; Grassi C; D'Adamio L; Kanaan NM; Fraser PE; Arancio O
    J Clin Invest; 2020 Sep; 130(9):4831-4844. PubMed ID: 32544084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Expression of the PP2A Methylesterase, PME-1, or the PP2A Methyltransferase, LCMT-1, Alters Sensitivity to Beta-Amyloid-Induced Cognitive and Electrophysiological Impairments in Mice.
    Staniszewski A; Zhang H; Asam K; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE
    J Neurosci; 2020 Jun; 40(23):4596-4608. PubMed ID: 32341098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on quinoline derivatives as anti-methicillin resistant
    Kumar P
    BMC Chem; 2020 Dec; 14(1):17. PubMed ID: 32190843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.
    Zuccarello E; Acquarone E; Calcagno E; Argyrousi EK; Deng SX; Landry DW; Arancio O; Fiorito J
    Biochem Pharmacol; 2020 Jun; 176():113818. PubMed ID: 31978378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.